A number of biologically relevant O 4 ‐phospho‐L‐tyrosine‐containing peptides have been synthesized by either the global phosphorylation of the side‐chain‐unprotected L‐tyrosine moiety in presynthesized resin‐bound peptides or alternatively by the incorporation of suitably protected O 4 ‐phospho‐L‐tyrosine building blocks in the continuous‐flow method of Fmoc solid‐phase peptide synthesis. Different phosphate‐protecting groups have been applied.
No takes yet. Share an insight, caveat, or question.
Kitas et al. (1991) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: